Michael chats with David Katz, chief scientific officer and founder of Sparrow Pharmaceuticals. Prior to founding Sparrow, David was a pharmaceutical R&D leader at Abbott and AbbVie, where he led clinical development and drug discovery teams and was a personalized medicine pioneer. He is currently an entrepreneur-in-residence at Oregon Health & Science University.

David held post-doctoral fellowships in immunology at the Universities of Chicago and Michigan and earned a B.A. in Chemistry at Pomona College and a Ph.D. in Molecular Biophysics and Biochemistry from Yale University. In this episode, David discusses the creation of Sparrow, the company’s work in developing new medicines for patients who have experienced the effects of excess steroids, and how, in his view, developing drugs is just as much of an art as it is a science.

This episode is sponsored by Sparrow Pharmaceuticals, sparrowpharma.com.